Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Lysosomal storage diseases (LSDs), of which about 50 are known, are caused by the defective activity of lysosomal proteins, resulting in accumulation of unmetabolized substrates. As a result, a variety of pathogenic cascades are activated such as altered calcium homeostasis, oxidative stress, inflammation, altered lipid trafficking, autophagy, endoplasmic reticulum stress, and autoimmune responses. Some of these pathways are common to many LSDs, whereas others are only altered in a subset of LSDs. We now review how these cascades impact upon LSD pathology and suggest how intervention in the pathways may lead to novel therapeutic approaches.

Original publication




Journal article


J Biol Chem

Publication Date





20423 - 20427


Antigens, CD, Autoimmune Diseases, Autophagy, Calcium, Endoplasmic Reticulum, Free Radicals, G(M2) Ganglioside, G(M3) Ganglioside, Gaucher Disease, Humans, Lactosylceramides, Lysosomal Storage Diseases, Lysosomes, Mitochondria, Oxidative Stress